Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125722411 | 12572241 | 1 | I | 20160712 | 20160719 | 20160719 | EXP | CA-PFIZER INC-2016348066 | PFIZER | 40.00 | YR | M | Y | 0.00000 | 20160719 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125722411 | 12572241 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | U | 11719 | |||||||||
| 125722411 | 12572241 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | U | 11719 | |||||||||
| 125722411 | 12572241 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 6 | SS | ANAKINRA | ANAKINRA | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 7 | SS | ANAKINRA | ANAKINRA | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 8 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
| 125722411 | 12572241 | 9 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
| 125722411 | 12572241 | 10 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 11 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 12 | SS | HYDROXYCHLOROQUINE SULFATE. | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 13 | SS | HYDROXYCHLOROQUINE SULFATE. | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 14 | SS | HYDROXYCHLOROQUINE SULFATE. | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 15 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 16 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 17 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 18 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 19 | SS | SIMPONI | GOLIMUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125722411 | 12572241 | 20 | SS | SIMPONI | GOLIMUMAB | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125722411 | 12572241 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125722411 | 12572241 | Abasia | |
| 125722411 | 12572241 | Drug dependence | |
| 125722411 | 12572241 | Drug effect decreased | |
| 125722411 | 12572241 | Muscular weakness | |
| 125722411 | 12572241 | Nausea | |
| 125722411 | 12572241 | Rheumatoid arthritis | |
| 125722411 | 12572241 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |